Enterocolitis due to Clostridium difficile is major emerging cause of death in the US. Between 1999 and 2012, C. diff. deaths rose by a staggering almost-10-fold increase, to 7,739 from 793. This paper has three goals. First, we present a demographic description of C. diff. mortality in the US since 1999. Second, we test a hypothesis that the increase in C. diff. deaths is due to population aging. We find that the emergence of this cause of death follows a proportional hazard pattern, above age 40. Thus, population aging is not the only factor responsible for the increase in C. diff. deaths. This, combined with a contributory cause of death analysis, points towards healthcare-based strategies to combat C. diff. Third, we demonstrate a simple weighted least squares technique for estimating Gompertz models that gives parameter estimates that are closer to full maximum likelihood, compared to conventional approaches.
threat level, "urgent", along with carbapenem-resistant Enterobacteriaceae (CRE) and drug-resistant Neisseria gonorrhoeae, noting: "Although C. difficile is not currently significantly resistant to antibiotics used to treat it, it was included in the threat assessment because of its unique relationship with resistance issues, antibiotic use, and its high morbidity and mortality." (National Center for Emerging Zoonotic and Infectious Diseases 2013). Table 1 shows the stark rise in deaths due to Clostridium difficile enterocolitis (ICD-10 A04.7) over a 14-year period. The United States began using ICD-10 for death codes in 1999, before which it is difficult to track C.
diff. mortality. The reason is that in the ICD-9 coding scheme, C. diff. deaths were coded as 008.45 (5-digit code), whereas the mortality detail files report only 4-digit ICD-9 codes. For example, in 1998 there were 600 deaths in the US with cause of death ICD-9 008.4, "intestinal infections due to other spec-ified bacteria", but we have no way of knowing how many were due to C.
diff. specifically. Note, however, 600 deaths for 1998 is in-line with the level and trend seen in table 1. The ICD-9 coding scheme originated in 1975, but C. diff. was fully recognized as a human pathogen two years later (Bartlett et al. 1977) , so it is not surprising that it was relegated to a 5-digit ICD code.
Only with promotion to 4-digit ICD code status in ICD-10 can demographers specifically track levels and trends of C. diff. mortality. Wysowski (2006) noted the increase in mortality due to C. diff., 1999-2002 . This work was expanded upon by Redelings et al. (2007) , who described the increase in C. diff. mortality, 1999-2004 , and included contributory as well as underlying deaths. Hall et al. (2012) updated the picture using data through 2007, and contrasted the relative lack of seasonality of C. diff. deaths compared to norovirus-associated mortality, which peaks in the winter. Using data up to 2009, Peery et al. (2012) noted "The toll of C. difficile infection is large and becoming more prominent". Writing in the official National Center for Health Statistics (NCHS) summary of mortality data, Murphy et al. (2012) , similarly noted, "Enterocolitis due to Clostridium difficile ... has become a growing concern in recent years"; it is unusual for the NCHS to call attention to a specific cause of death in this way.
A goal of this study is to present a descriptive analysis of levels and changes in C. diff. mortality in the United States during the ICD-10 era for mortality coding (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) . Because C. diff. death rates rise with age, the aging of the US population (Ortman et al. 2014) could potentially account for an increase in the number of C. diff. deaths even if age-and cause-specific rates do not change. We know, a priori, that a nearly 10-fold increase in deaths in 14 years (cf. table 1) must have a causal component beyond population aging, but nonetheless it is desirable to describe the age-mortality profile for C. diff., and whether it has changed over time.
We present underlying-cause and any-mention mortality rates for C.
diff. infection, by age (5-year groups) and sex, calculated from data on every death in the US. We use cause-specific Gompertz models to test a proportional hazard hypothesis, and we introduce therein a weighted least squares technique for estimating Gompertz survival curves.
Clostridium difficile mortality
We used data from the multiple cause of death files of the National Center The "lazy-J" pattern seen in the age-mortality profile is typical of many causes of death. What is noteworthy is that above age 40, the death rates for 2006-2012 parallel the 1999-2005 rates. In other words, the increase in C. diff. death rates over time, seen in figure 1, cannot be attributed to changes in a specific age group. In fact, above age 40, it is truly striking just how uniform by age is the increase in the C. diff. mortality rate; a proportional hazard phenomenon, in other words.
To test statistically the above assertion (i.e., that above age 40, the later period is a proportional hazard of the earlier period), we used Gompertz mortality models. We estimated the following model:
where M(·) is the C. diff. cause-specific death rate, x is age, α and β are parameters to be estimated, and ǫ is an error term with presumed zero mean. male and female hazards often behave differently (Kohler and Kohler 2000) , although in this case there is no qualitative distinction between the shapes or levels of the graph by sex, above age 40 (cf. figure 2). Five-year age groups, , 40-44, 45-49, . . . ) , were used to smooth age heaping. In each age group, the mean age of C. diff. mortality in the interval was used as the x value in the regressions. For example, for females age 65-69 in the more recent time period, the mean age of death due to C. diff. was 67.153, so this value was used as x instead of the midpoint of the interval, 67.5.
This "centering" of the x values is used to polish the estimates, although it has small effects. Such centering, combined with parametric estimation of mortality, can help avoid some of the methodological pitfalls outlined by Gelman and Auerbach (2016) . Table 2 gives the weighted least squares (WLS) regression results.
The weights are the numbers of C. diff. deaths in each age×sex×period cell; this is numerator-weighted rate regression, in other words. The use of death counts as weights has two appealing properties. First, it effectively downweights data at the extremes of the age range, where deaths are fewer.
This has the desirable consequence of reducing the importance of subjective choices of age range (for instance, whether to use data beginning at age 40 or at age 45). Second, it moves the parameter estimates closer to those that would be achieved by maximum likelihood (ML) estimationwhich can regarded as theoretically desirable (Brillinger 1986 ) -but without the computational expense of ML. To the best of our knowledge, this approach (using WLS expressly to approximate ML estimates) has not been used before. Therefore, we provide, in the Appendix, a demonstration of our assertion that the WLS estimates are indeed better than -and not just different from -the OLS estimates (with the proviso that better in this context means closer to ML). Note also that, judging by the high R 2 values in table 2, the Gompertz specification seems to be very appropriate for C. diff.
cause-specific mortality.
The test of the proportional hazard comes from an interactive model.
Rather than run each period separately, we estimated the model using data from both periods, pooled:
where p is an indicator variable for the later period, γ and δ are additional parameters to be estimated, and ε is an error term like before. Thus, α is the intercept, β is the age term, γ is the period term, and δ is the age×period intercept term. This model recapitulates the coefficients from the earlier models, but permits a statistical test for differences of slopes (i.e., δ = 0). In model 3 of table 2, the α and β values are not shown because they coincide exactly with those of model 1. All analysis was conducted using Stata 13.1.
The proportional hazard assumption is upheld; we fail to reject the null hypothesis that δ = 0 for both sexes. The differences in slopes across the two time periods are not only negligible in magnitude, but are not dis- To complete our empirical analysis, table 3 summarizes the underlying causes of death when C. diff. infection was a contributory cause on the death certificate; the importance of multiple-cause analysis is noted by Dés-esquelles et al. (2014) . Table 3 Table 3 is fully consistent with this.
For example, diseases of the circulatory system (ICD-10 Ixx.x) account for over 40% of deaths in which C. diff. is a contributory cause. While some mortality in this group may not be preceded by a hospital stay (for example, sudden death due to stroke or heart attack), admission to the emergency department and/or intensive care unit is common with these diseases (see ICD-10 "I" causes in table 3). Also, nearly 30% of deaths in which C. diff. is a contributory cause involve neoplasms (cancer, ICD-10 Cxx.x). Cancer is clearly a disease that involves interaction with healthcare prior to mortality.
Moreover, immunosuppression is a risk factor for cancer (Vial and Descotes 2003) as well as infection. In short, table 3 shows that when C. diff. infec- 
Conclusions
The increase in C. diff. mortality rates since 1999 in the US has occurred at all ages > 40. The pronounced proportional hazard pattern ( In summary, in addition to causing significant morbidity (Lessa et al. 2015) , Clostridium difficile is an emerging cause of death in the United States.
C. diff. mortality rates have increased profoundly in the last 14 years, evenly for all ages above 40, and for both sexes. Despite the overall increase, C. diff.
mortality rates have plateaued in the most recent years. The emergence of C.
diff. mortality is associated with new strains, and the plateau with the switch to vancomycin therapy (Bartlett 2008b). Promising experimental therapies include strain-specific probiotics , as well as more di-verse gut microbiome-related approaches (e.g., Rupnik 2015 , Buffie et al. 2015 .
One limitation of this study is that C. diff. mortality is probably the "tip of the iceberg" of infection, on which we do not have data. Moreover, the elderly, who are hospitalized disproportionately and for longer stays, may play a catalyzing role in the epidemiology of C. diff. in ways that are not captured by the mortality rates, which we have asserted are not rising in an age-specific way.
Especially because of the broad age range of increased mortality and the nonspecific nature of observed co-morbidities, public health agencies should closely monitor C. diff. mortality. The most important substantive lesson from this study is that the emergence of C. diff. as a cause of death in the United States is not due to population aging, but is healthcare-associated.
We also demonstrate weighted least squares (WLS) regression as an approximation to full maximum likelihood for Gompertz parameter estimation, and we strongly recommend WLS over OLS whenever weights are available.
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